Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Informationsteknik |
| Industri | Programvara |
26.4.2021 17:29:33 CEST | Monsenso | Managers' transactions
Company announcement no. 11-2021
Copenhagen, 2021.04.26
With reference to company announcement no. 10 regarding the issuance of warrants to the management and employees, Monsenso A/S hereby reports further details on granting of warrants to the management.
Details of the person discharging managerial responsibilities/person closely associated:
| Name | Thomas Lethenborg |
Reason for the notification:
| Position/status: | CEO |
| Initial notification/Amendment: | Initial notification |
Details of the issuer, emmision allowance market participant, auction platform, auctioneer or auction monitor:
| Name: | Monsenso A/S |
| LEI code: | 52990024UWU19T5URJ57 |
Details of the transaction(s):
| Description of instrument | Shares |
| Identification code | ISIN DK0061277977 |
| Nature of transaction | Granting of warrants |
| Price(s) | DKK 5.86/share |
| Volume(s) | 100,000 |
| Aggregated volume | N/A |
| Aggregated price | N/A |
| Date of the transaction | 2021-04-23 |
| Place of the transaction | Nasdaq First North Growth Market Denmark |
Any requiries regarding this notice should be directed to:
Monsenso
Chairman of the board
Maria Hjorth
Tel. +45 25 55 63 39
E-mail: maria.hjorth@gmail.com
CEO
Thomas Lethenborg
Tlf. +45 21 29 88 27
E-mail: lethenborg@monsenso.com
Certified Adviser
Norden CEF ApS
John Norden
Tlf. +45 20 72 02 00
E-mail: jn@nordencef.dk
About Monsenso
Monsenso is an innovative technology company offering a digital health solution for mental health and behavioral disorders. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit www.monsenso.com